Lymphovascular Invasion Is Associated With Doxorubicin Resistance in Breast Cancer

被引:0
|
作者
Corachea, Allen Joy M. [1 ]
Ferrer, Regina Joyce E. [1 ]
Ty, Lance Patrick B. [1 ]
Aquino, Lizzie Anne C. [2 ]
Morta, Madeleine T. [1 ]
Macalindong, Shiela S. [2 ]
Uy, Gemma Leonora B. [2 ]
Odono, Eugene G. [3 ]
Llames, Jo-Hannah S. [4 ]
Tablizo, Francis A. [4 ]
Paz, Eva Maria C. Cutiongco-Dela [5 ]
Dofitas, Rodney B. [2 ]
Velarde, Michael C. [1 ]
机构
[1] Univ Philippines Diliman, Inst Biol, Coll Sci, Quezon City, Philippines
[2] Univ Philippines Manila, Philippine Gen Hosp, Dept Surg, Manila, Philippines
[3] Univ Philippines Manila, Philippine Gen Hosp, Dept Pathol, Manila, Philippines
[4] Univ Philippines, Philippine Genome Ctr, Quezon City, Philippines
[5] Univ Philippines Manila, NIH, Manila, Philippines
关键词
breast cancer; lymphovascular invasion; drug resistance; patient-derived organoids; SURGICAL ADJUVANT BREAST; NEOADJUVANT TREATMENT; ENRICHMENT ANALYSIS; CYP1B1; INHIBITORS; DOCETAXEL; DISEASE; MODELS;
D O I
10.1016/j.labinv.2025.104115
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lymphovascular invasion (LVI), the invasion of tumor cells into the lymphatic or vascular space, is an early indicator of potential metastasis, with its presence in breast cancer independently predicting poorer outcomes even after neoadjuvant chemotherapy. However, a major limitation is that LVI detection currently relies on postsurgical evaluation. To address this, we determined whether LVI+ breast tumors contain a unique gene signature that could facilitate earlier detection. Here, we conducted an integrative analysis of the gene profile between LVI+ and LVI- primary breast tumors from various sources, including published data and our own research, using both microarray and RNA-seq data. Our analysis revealed protein binding and vesicle-related genes to be the most enriched categories in LVI+ vs LVI- tumors. Furthermore, LVI+ tumors showed enrichment for xenobiotic metabolism genes, particularly drug metabolism enzymes, such as cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases. An elastic net regression model containing 13 of these uridine 5'-diphospho-glucuronosyltransferases and cytochrome P450 genes can predict LVI status with 92% accuracy. This suggests a potential link to drug resistance, which was further confirmed by the finding that patients with LVI+ tumors had a significantly lower clinical response rate than individuals with LVI- tumors. We also observed this resistance in patient-derived organoids, with LVI+ organoids exhibiting lower sensitivity to doxorubicin, implying that doxorubicin might be less effective for LVI+ breast cancer, potentially contributing to poorer outcomes. Overall, our study unlocked an exciting opportunity for personalized medicine, in that, therapy efficacy and patient outcomes can be improved by incorporating the LVI-associated gene signature into treatment plans. (c) 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
    Mariko Asaoka
    Santosh K. Patnaik
    Frank Zhang
    Takashi Ishikawa
    Kazuaki Takabe
    Breast Cancer Research and Treatment, 2020, 181 : 309 - 322
  • [32] Ki-67 EXPRESSION CORRELATED WITH LYMPHOVASCULAR INVASION IN BREAST CANCER
    Lee, Yueh-Tsung
    Lin, Ho
    Lai, Ming-Tsung
    Guo, Zhen-Chang
    Chen, Cheng-Te
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 541 - 541
  • [33] Diagnostic Values of Ultrasound and Mammography on Prediction of Lymphovascular Invasion in Breast Cancer
    Bahrami, Mahshid
    Hasani, Seyed Hamidreza
    Karami, Fatemeh
    Karami, Mojtaba
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 23 (01)
  • [34] Lymphovascular Invasion in BRCA Related Breast Cancer Compared to Sporadic Controls
    van der Groep, P.
    van Voss, Heerma M.
    Bart, J.
    van der Wall, E.
    van Diest, P. J.
    CANCER RESEARCH, 2009, 69 (24) : 829S - 830S
  • [35] Lymphovascular invasion in breast cancer: improved methods of detection and clinical significance
    Mohammed, R. A. A.
    Martin, S. G.
    Gill, M. S.
    Green, A. R.
    Paish, E. C.
    Ellis, I. O.
    BREAST CANCER RESEARCH, 2008, 10 (Suppl 2) : S37 - S37
  • [36] Lymphovascular Invasion in Breast Cancer and its Association with Other Pathological Variables
    Gill, M. S.
    Azad, N. S.
    Jahan, M. A.
    Mukherjee, A.
    JOURNAL OF PATHOLOGY, 2016, 240 : 25 - 25
  • [37] MED7 in Breast Cancer: Relationship to Grade and Lymphovascular Invasion
    Macnamara, O.
    Joseph, C.
    Craze, M.
    Rakha, E. A.
    Russell, R.
    Rueda, O. M.
    Provenzano, E.
    Caldas, C.
    Ellis, I. O.
    Mukherjee, A.
    JOURNAL OF PATHOLOGY, 2015, 237 : S31 - S31
  • [38] Lymphovascular invasion and survival in breast cancer after neoadjuvant chemotherapy.
    Liu, Ying
    Saraf, Anurag
    Lee, Shing Mirn
    Zhong, Xiaobo
    Kalinsky, Kevin
    Connolly, Eileen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] The Impact of Lymphovascular Invasion on Lymph Node Status in Patients with Breast Cancer
    Cornwell, Laura B.
    McMasters, Kelly M.
    Chagpar, Anees B.
    AMERICAN SURGEON, 2011, 77 (07) : 874 - 877
  • [40] Identification of genes and pathways related to lymphovascular invasion in breast cancer patients
    Wong, Henry Sung-Ching
    Klahan, Sukhontip
    Tu, Shih-Hsin
    Chou, Wan-Hsuan
    Zhang, Yan-Feng
    Ho, Thien-Fiew
    Liu, Chih-Yu
    Lu, Hsing-Fang
    Chen, Sean Chun-Chang
    Huang, Chi-Cheng
    Chang, Wei-Chiao
    CANCER SCIENCE, 2018, 109 : 193 - 193